Tanox to Report Second Quarter 2006 Financial Results, Host Conference Call for Investors Aug. 8
18 Juillet 2006 - 3:00PM
PR Newswire (US)
HOUSTON, July 18 /PRNewswire-FirstCall/ -- Tanox, Inc.
(NASDAQ:TNOX) will report its 2006 second quarter financial results
Aug. 8, 2006. The announcement will be made prior to market open,
with a conference call for the financial community to follow at 10
a.m., EDT. Tanox President and Chief Executive Officer Danong Chen,
Ph.D. and Vice President of Finance Greg Guidroz will outline
results for the quarter, provide an update on the company's
operations and pipeline, and lead a question-and-answer session.
Live audio of the conference call will be simultaneously webcast on
the Internet. The webcast will be accessible from the Tanox Web
site at http://www.tanox.com/ in the Investor Relations section.
About Tanox, Inc. Tanox is a biotechnology company specializing in
the discovery and development of monoclonal antibodies. The company
develops innovative biotherapeutics for the treatment of
immune-mediated diseases, inflammation, infectious disease and
cancer. Tanox's lead investigational therapy, TNX-355, is a
viral-entry inhibitor antibody to treat HIV/AIDS. TNX-355 has shown
significant antiviral activity in Phase 2 clinical testing. Tanox's
first- approved drug, Xolair(R) (omalizumab), is the first antibody
approved to treat moderate-to-severe confirmed allergic asthma.
Xolair was developed in collaboration with Genentech, Inc. and
Novartis Pharma AG and is approved for marketing in the United
States, Canada and major European countries. Tanox is based in
Houston and has a manufacturing facility in San Diego. Additional
corporate information is available at http://www.tanox.com/ .
http://www.newscom.com/cgi-bin/prnh/20050207/TNOXLOGO DATASOURCE:
Tanox, Inc. CONTACT: Steve Sievert of Tanox, Inc., +1-713-578-4211,
or Web site: http://www.tanox.com/
Copyright
Tanox (NASDAQ:TNOX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Tanox (NASDAQ:TNOX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Tanox (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Tanox (MM)